TY  - GEN
AU  - Ganzinelli,Monica
AU  - Rulli,Eliana
AU  - Caiola,Elisa
AU  - Garassino,Marina Chiara
AU  - Broggini,Massimo
AU  - Copreni,Elena
AU  - Piva,Sheila
AU  - Longo,Flavia
AU  - Labianca,Roberto
AU  - Bareggi,Claudia
AU  - Fabbri,Maria Agnese
AU  - Martelli,Olga
AU  - Fagnani,Daniele
AU  - Locatelli,Maria Cristina
AU  - Bertolini,Alessandro
AU  - Valmadre,Giuseppe
AU  - Pavese,Ida
AU  - Calcagno,Anna
AU  - Sarobba,Maria Giuseppa
AU  - Marabese,Mirko
TI  - Role of KRAS-LCS6 polymorphism in advanced NSCLC patients treated with erlotinib or docetaxel in second line treatment (TAILOR)
SN  - 2045-2322
PY  - 2016///0926
KW  - 3' Untranslated Regions
KW  - Aged
KW  - Alleles
KW  - Carcinoma, Non-Small-Cell Lung
KW  - drug therapy
KW  - Disease-Free Survival
KW  - Docetaxel
KW  - Erlotinib Hydrochloride
KW  - therapeutic use
KW  - Female
KW  - Genotype
KW  - Humans
KW  - Kaplan-Meier Estimate
KW  - Lung Neoplasms
KW  - Male
KW  - MicroRNAs
KW  - genetics
KW  - Middle Aged
KW  - Polymorphism, Single Nucleotide
KW  - Proportional Hazards Models
KW  - Taxoids
KW  - ras Proteins
N1  - Publication Type: Journal Article; Multicenter Study; Randomized Controlled Trial; Research Support, Non-U.S. Gov't
UR  - https://doi.org/10.1038/srep16331
ER  -